tiprankstipranks
CANbridge Pharmaceuticals Inc. (HK:1228)
:1228
Hong Kong Market
1228
CANbridge Pharmaceuticals Inc.
RESEARCH TOOLSreports

CANbridge Pharmaceuticals Inc. (1228) Income Statement

0 Followers

CANbridge Pharmaceuticals Inc. Income Statement

Last quarter (Q2 2025), CANbridge Pharmaceuticals Inc.'s total revenue was ¥11.12M, a decrease of -50.33% from the same quarter last year. In Q2, CANbridge Pharmaceuticals Inc.'s net income was ¥29.62M. See CANbridge Pharmaceuticals Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 85.10M¥ 102.87M¥ 78.97M¥ 31.16M¥ 12.03M
Gross Profit
¥ 54.30M¥ 64.16M¥ 48.89M¥ 18.78M¥ 6.88M
Operating Expenses
¥ 394.82M¥ 429.28M¥ 506.86M¥ 673.52M¥ 237.97M
Depreciation and Amortization
¥ 11.82M¥ 28.46M¥ 21.98M¥ 15.71M¥ 17.84M
EBITDA
¥ -328.69M¥ -341.43M¥ -454.63M¥ -1.06B¥ -824.41M
Operating Income
¥ -340.51M¥ -366.55M¥ -457.97M¥ -655.15M¥ -231.09M
Other Income/Expenses
¥ -102.10M¥ -12.29M¥ -25.51M¥ -421.86M¥ -614.95M
Pretax Income
¥ -442.62M¥ -378.84M¥ -483.48M¥ -1.08B¥ -846.04M
Net Income
¥ -442.62M¥ -378.84M¥ -483.48M¥ -1.08B¥ -846.04M
Per Share Metrics
Basic EPS
¥ -1.04¥ -0.89¥ -1.14¥ -11.43¥ -11.90
Diluted EPS
¥ -1.04¥ -0.89¥ -1.14¥ -11.43¥ -11.90
Weighted Average Shares Outstanding
 424.83M 424.38M 424.21M 94.24M 71.12M
Weighted Average Shares Outstanding (Diluted)
 424.83M 424.38M 424.21M 94.24M 71.12M
Currency in CNY

CANbridge Pharmaceuticals Inc. Earnings and Revenue History